News
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and ...
Investing.com -- Equillium Inc (NASDAQ: EQ) stock tumbled 12.4% after the biotechnology company announced plans to integrate cryptocurrency into its treasury reserve strategy, a significant deviation ...
As the U.S. markets react to recent economic uncertainties, including weak job reports and tariff concerns, investors are reassessing their strategies amid fluctuating indices. In this context, penny ...
2d
InvestorsHub on MSNEquillium Shares Drop 12.4% After Unveiling Cryptocurrency Treasury StrategyEquillium Inc (NASDAQ:EQ) stock plunged 12.4% following the company’s announcement that it will integrate cryptocurrency ...
Shares of CommScope Holding Company, Inc. COMM +44.4% Get Free Report rose sharply in pre-market trading. The Wall Street Journal reported Sunday that Amphenol is nearing a deal for CommScope’s ...
Wimbledon champion Jannik Sinner has reappointed his former fitness trainer, who he sacked following his positive doping tests last year. Sinner parted ways with his fitness coach Umberto Ferrara and ...
Premier League club Brentford FC’s main sponsor, Hollywoodbets, has been rapped by the advertising watchdog for targeting children. The Advertising Standards Authority today upheld a complaint from a ...
The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic ...
The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results